Domingos Silva is patent counsel in the Intellectual Property & Technology Practice who brings to clients extensive experience in the chemical, materials science, pharmaceutical, diagnostics, biotechnology, and biochemistry areas.
Domingos has a long professional history in the science field. After obtaining a Ph.D. in Organic Chemistry from Princeton and pursuing his post-doctorate fellowship work at MIT, Domingos embarked on a career as a research scientist for Incara Research Labs, and later as medicinal chemistry manager in the oncology and antibacterial programs for GlaxoSmithKline. As a medicinal chemist, Domingos co-authored 16 peer-reviewed publications, and was named as in inventor in 17 patent applications. At GlaxoSmithKline, he was a member of the development team for a novel kinase inhibitor, which was eventually approved by the FDA as an oral antitumor agent.
Domingos became a registered patent agent in 2009. Prior to joining Saul Ewing Arnstein & Lehr, Domingos worked for a boutique intellectual property firm and a large Philadelphia law firm. Domingos drafts and prosecutes patent applications in the areas of pharmaceutical sciences (including drug formulation and delivery, novel chemical entities, and repurposing of known drugs), chemistry (including inorganic, organic and bioorganic), diagnostics, biotechnology and materials sciences. He also performs prior art searches, and drafts legal opinions (including patentability, due diligence and freedom-to-operate).
A native of Rio de Janeiro, Brazil, Domingos is fluent in Portuguese and has a good understanding of Spanish.